A microbiologist works with tubes of bacteria samples in an antimicrobial resistance and characterization lab within the Infectious Disease Laboratory at the Centers for Disease Control and Prevention in Atlanta on November 25, 2013. Antimicrobial resistance is likely to kill nearly 400,000 Canadians and cost the economy about $400 billion in gross domestic product over the next 30 years, warns a landmark new report. An expert panel cautions in “When Antibiotics Fail: The growing cost of antimicrobial resistance in Canada” that the percentage of bacterial infections that are resistant to the drugs used to treat them is likely to grow from 26 per cent in 2018 to 40 per cent by 2050. THE CANADIAN PRESS/AP, David Goldman

A microbiologist works with tubes of bacteria samples in an antimicrobial resistance and characterization lab within the Infectious Disease Laboratory at the Centers for Disease Control and Prevention in Atlanta on November 25, 2013. Antimicrobial resistance is likely to kill nearly 400,000 Canadians and cost the economy about $400 billion in gross domestic product over the next 30 years, warns a landmark new report. An expert panel cautions in “When Antibiotics Fail: The growing cost of antimicrobial resistance in Canada” that the percentage of bacterial infections that are resistant to the drugs used to treat them is likely to grow from 26 per cent in 2018 to 40 per cent by 2050. THE CANADIAN PRESS/AP, David Goldman

Report predicts drug resistance likely to kill 400,000 Canadians by 2050

This increase is expected to cost Canada 396,000 lives, $120 billion in hospital expenses

Superbugs are likely to kill nearly 400,000 Canadians and cost the economy about $400 billion in gross domestic product over the next 30 years, warns a landmark report.

An expert panel cautions in “When Antibiotics Fail: The growing cost of antimicrobial resistance in Canada” that the percentage of bacterial infections that are resistant to treatment is likely to grow from 26 per cent in 2018 to 40 per cent by 2050.

This increase is expected to cost Canada 396,000 lives, $120 billion in hospital expenses and $388 billion in gross domestic product over the next three decades.

“This is almost as big, if not bigger, than climate change in a sense because this is directly impacting people. The numbers are just staggering,” says Brett Finlay, a University of British Columbia microbiology professor who chaired the panel, in an interview. “It’s time to do something now.”

The Public Health Agency of Canada commissioned the report on the socio-economic impacts of antimicrobial resistance and the Council of Canadian Academies assembled the independent panel. The 268-page document released Tuesday represents the most comprehensive picture to date of the country’s resistance rate as well as its costs to the health system and economy.

Antimicrobial resistance occurs when micro-organisms, including bacteria, viruses and fungi, evolve to resist the drugs that would otherwise kill them. Unnecessary antimicrobial use in humans and agriculture exacerbates the problem and widespread international travel and trade help resistant bacteria spread across the globe.

The most common antimicrobials are antibiotics, which treat infections caused by bacteria. The report focuses on resistant bacteria but uses the broader term antimicrobial because surveillance data tend to be collected under this heading.

An investigation by The Canadian Press last year revealed Canada has been sluggish to act on the growing threat. At that time, the federal government did not know how many Canadians were dying of resistant infections and it had not produced a plan that lays out responsibilities for provinces and territories.

A pan-Canadian action plan has still not materialized, but the new report estimates an annual death toll in Canada. The panel used the current resistance rate of 26 per cent to calculate that resistant infections contributed to over 14,000 deaths in 2018, and of those, 5,400 were directly attributable to the infections — only slightly less than those caused by Alzheimer’s disease.

ALSO READ: Flu season off to a fairly average start in B.C.: report

The panel’s economists used a more cautious model to project the impacts than a well-known international report by British economist Jim O’Neill, which predicted up to 10 million global deaths annually by 2050.

The Canadian report’s findings on the economic and social toll of antimicrobial resistance are stark. Currently, the problem costs the national health-care system $1.4 billion a year and by 2050, that figure is projected to grow to $7.6 billion, the report says. The cost to GDP is expected to jump from $2 billion to up to $21 billion annually.

Resistant infections decrease quality of life while increasing isolation and stigma and the impact will be unequally distributed as some socio-economic groups are more at risk, the report adds. These groups include Indigenous, low-income and homeless people, as well as those who travel to developing countries where resistant microbes are more common.

“Discrimination may be targeted at those with resistant infections or deemed to be at risk of infection,” the report warns. “Canadian society may become less open and trusting, with people less likely to travel and more supportive of closing Canada’s borders to migration and tourists.”

Antimicrobial resistance has the potential to impact everyone, Finlay says.

“It’s going to change the world,” he says. “We all go to hospitals and we all get infections.”

The report notes that resistance could increase the risk and reduce the availability of routine medical procedures including kidney dialysis, joint replacement, chemotherapy and caesarean section. These procedures all carry a threat of infections for which antibiotics are commonly prescribed.

Limiting the impacts of antimicrobial resistance requires a “complete re-evaluation” of health care in Canada, the report concludes.

The panel states that Canada lacks an effective federal, provincial and territorial surveillance system of antimicrobial resistance and use, with little comprehensive data describing the number of resistant infections and their characteristics.

It also calls for improved stewardship involving careful use of antimicrobials to preserve their effectiveness, strict infection prevention and control through hand hygiene, equipment cleaning and research and innovation for new treatments.

The report notes it’s unlikely that new broad-spectrum antimicrobials will be discovered. None have been found in decades and there’s little profit incentive for pharmaceutical companies to invest in drugs that quickly cure patients. However, the panel calls for more flexible regulations and incentives to promote discovery of new antimicrobials that treat infections caused by specific bacteria.

Alternative therapies are also being developed to treat or prevent resistant infections, including vaccines and treatments using phages, which are viruses that attack bacteria, the report adds.

Canada should immediately invest $120 million in research and innovation and up to $150 million in stewardship, education and infection control, matched by the provinces and territories, says Dr. John Conly, a panel member and University of Calgary professor specializing in chronic diseases.

The government and public should “absolutely” be as concerned about antimicrobial resistance as they are about climate change, Conly says.

“It’s a slow-moving tsunami. Like a tidal wave, it’s out at sea but it’s going to land on us much sooner than climate change.”

ALSO READ: Don Cherry says he was fired, not sorry for ‘Coach’s Corner’ poppy rant

Laura Kane, The Canadian Press


Like us on Facebook and follow us on Twitter.

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

The Lake Cowichan Legion received federal funding in December, 2020 to help the organization weather the COVID-19 pandemic. (Submitted)
Lake Cowichan Legion receives federal COVID-19 assistance funding

Can be used for expenses such as insurance, utilities, rent or mortgages, property taxes, and wages.

Tim Schewe
Drivesmart column: Do you know someone who should not be driving?

We are currently living about 10 years longer than our ability to drive safely.

Chris Wilkinson
Chris Wilkinson column: Time to slow down to speed up

In a society where we learn (are forced?) to multitask like crazy

A COVID-19 exposure has been reported at Shawnigan Lake School. (Citizen file photo)
UPDATED: Island Health reports COVID-19 exposure at Shawnigan Lake School

Shawnigan Lake School has been added to the list of schools in… Continue reading

Terrance Josephson of the Princeton Posse, at left, and Tyson Conroy of the Summerland Steam clash during a Junior B hockey game at the Summerland Arena in the early spring of 2020. (John Arendt - Summerland Review)
QUIZ: How much do you know about hockey?

Test your knowledge of Canada’s national winter sport

A woman injects herself with crack cocaine at a supervised consumption site Friday, Jan. 22, 2021 in Ottawa. THE CANADIAN PRESS/Adrian Wyld
Drug users at greater risk of dying as services scale back in second wave of COVID-19

It pins the blame largely on a lack of supports, a corrupted drug supply

Cannabis bought in British Columbia (Ashley Wadhwani/Black Press Media)
Is it time to start thinking about greener ways to package cannabis?

Packaging suppliers are still figuring eco-friendly and affordable packaging options that fit the mandates of Cannabis Regulations

Wet’suwet’en supporters and Coastal GasLink opponents continue to protest outside the B.C. Legislature in Victoria, B.C., on Thursday, February 27, 2020. THE CANADIAN PRESS/Chad Hipolito
‘We’re still in it’: Wet’suwet’en push forward on rights recognition

The 670-km Coastal GasLink pipeline was approved by B.C. and 20 elected First Nations councils on its path

The sky above Mt. Benson in Nanaimo is illuminated by flares as search and rescuers help an injured hiker down the mountain to a waiting ambulance. (Photo courtesy Nanaimo Search and Rescue)
Search plane lights up Nanaimo mountain with flares during icy rope rescue

Rescuers got injured hiker down Mt. Benson to a waiting ambulance Saturday night

Jennifer Cochrane, a Public Health Nurse with Prairie Mountain Health in Virden, administers the COVID-19 vaccine to Robert Farquhar with Westman Regional Laboratory, during the first day of immunizations at the Brandon COVID-19 vaccination supersite in Brandon, Man., on Monday, January 18, 2021. THE CANADIAN PRESS/Tim Smith - POOL
Top doctor urges Canadians to keep up with COVID measures, even as vaccines roll out

More than 776,606 vaccines have been administered so far

From the left: Midway RCMP Csts. Jonathan Stermscheg and Chris Hansen, Public Servant Leanne Mclaren and Cpl. Phil Peters. Pictured in the front are Mclaren’s dog, Lincoln and Peters’ dog, Angel. Photo courtesy of BC RCMP
B.C. Mounties commended for bringing firewood to elderly woman

Cpl. Phil Peters said he and detachment members acted after the woman’s husband went to hospital

Dr. Jerome Leis and Dr. Lynfa Stroud are pictured at Sunnybrook Hospital in Toronto on Thursday, January 21, 2021.THE CANADIAN PRESS/Frank Gunn
‘It wasn’t called COVID at the time:’ One year since Canada’s first COVID-19 case

The 56-year-old man was admitted to Toronto’s Sunnybrook Health Sciences Centre

An Uber driver’s vehicle is seen after the company launched service, in Vancouver, Friday, Jan. 24, 2020. Several taxi companies have lost a court bid to run Uber and Lyft off the road in British Columbia. THE CANADIAN PRESS/Darryl Dyck
Taxi companies lose court bid to quash Uber, Lyft approvals in British Columbia

Uber said in a statement that the ruling of the justice is clear and speaks for itself

Most Read